Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
5-Methylcytosine | 14 | 2021 | 147 | 3.270 |
Why?
|
Melanoma | 31 | 2024 | 5706 | 2.280 |
Why?
|
Cytosine | 5 | 2015 | 213 | 2.100 |
Why?
|
Skin Neoplasms | 27 | 2023 | 5863 | 1.810 |
Why?
|
Facial Transplantation | 12 | 2023 | 221 | 1.790 |
Why?
|
Graft Rejection | 27 | 2024 | 4492 | 1.170 |
Why?
|
Nevus | 3 | 2014 | 205 | 1.150 |
Why?
|
Nevus, Pigmented | 4 | 2017 | 222 | 1.090 |
Why?
|
Dioxygenases | 8 | 2021 | 353 | 1.010 |
Why?
|
Hair Follicle | 2 | 2024 | 219 | 0.950 |
Why?
|
Epigenesis, Genetic | 10 | 2019 | 3833 | 0.900 |
Why?
|
Sweat Gland Neoplasms | 2 | 2020 | 111 | 0.720 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2020 | 82 | 0.670 |
Why?
|
Precancerous Conditions | 2 | 2017 | 985 | 0.620 |
Why?
|
Skin | 14 | 2024 | 4505 | 0.610 |
Why?
|
Phthirus | 1 | 2016 | 1 | 0.540 |
Why?
|
Sweat Gland Diseases | 1 | 2016 | 12 | 0.540 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2021 | 8648 | 0.540 |
Why?
|
Lice Infestations | 1 | 2016 | 8 | 0.540 |
Why?
|
Cell Hypoxia | 1 | 2019 | 662 | 0.530 |
Why?
|
Ichthyosis, Lamellar | 1 | 2015 | 11 | 0.510 |
Why?
|
Lipoxygenase | 1 | 2015 | 72 | 0.510 |
Why?
|
Ascorbic Acid | 1 | 2019 | 658 | 0.500 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.480 |
Why?
|
Pyrrolizidine Alkaloids | 1 | 2014 | 10 | 0.480 |
Why?
|
Aristolochic Acids | 1 | 2014 | 13 | 0.480 |
Why?
|
Dermatitis | 1 | 2016 | 203 | 0.470 |
Why?
|
Facial Dermatoses | 1 | 2014 | 87 | 0.450 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2014 | 103 | 0.450 |
Why?
|
Codon, Nonsense | 1 | 2015 | 287 | 0.450 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 99 | 0.450 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 620 | 0.440 |
Why?
|
Skin Transplantation | 7 | 2022 | 1097 | 0.440 |
Why?
|
Carcinoma, Small Cell | 1 | 2015 | 419 | 0.430 |
Why?
|
Proto-Oncogene Proteins | 7 | 2021 | 4528 | 0.430 |
Why?
|
DNA-Binding Proteins | 11 | 2021 | 9617 | 0.430 |
Why?
|
Carcinogens | 1 | 2014 | 453 | 0.400 |
Why?
|
Mouth Neoplasms | 1 | 2017 | 597 | 0.390 |
Why?
|
Ultraviolet Rays | 2 | 2018 | 1103 | 0.390 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2021 | 4058 | 0.370 |
Why?
|
Homozygote | 1 | 2015 | 1779 | 0.350 |
Why?
|
Stem Cells | 4 | 2022 | 3538 | 0.350 |
Why?
|
Autoimmunity | 2 | 2022 | 1361 | 0.340 |
Why?
|
Epigenomics | 1 | 2015 | 960 | 0.340 |
Why?
|
Alopecia | 1 | 2024 | 416 | 0.330 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2020 | 75 | 0.330 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2024 | 80 | 0.330 |
Why?
|
Pityriasis Rubra Pilaris | 2 | 2020 | 20 | 0.330 |
Why?
|
DNA Methylation | 9 | 2021 | 4428 | 0.310 |
Why?
|
Fluorescent Antibody Technique | 4 | 2024 | 2474 | 0.310 |
Why?
|
Fibroblasts | 1 | 2019 | 4178 | 0.300 |
Why?
|
Pemphigoid, Bullous | 2 | 2020 | 110 | 0.300 |
Why?
|
Immune Tolerance | 5 | 2023 | 2323 | 0.300 |
Why?
|
Immunohistochemistry | 8 | 2022 | 11095 | 0.290 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 923 | 0.290 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1896 | 0.280 |
Why?
|
Cell Differentiation | 5 | 2022 | 11677 | 0.270 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2914 | 0.270 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2024 | 3115 | 0.260 |
Why?
|
Cell Proliferation | 5 | 2019 | 10478 | 0.260 |
Why?
|
Humans | 95 | 2024 | 768171 | 0.260 |
Why?
|
Gene Expression Profiling | 5 | 2018 | 9540 | 0.260 |
Why?
|
Keratinocytes | 3 | 2019 | 876 | 0.240 |
Why?
|
Animals | 51 | 2024 | 169285 | 0.240 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2018 | 210 | 0.240 |
Why?
|
Lymph Nodes | 3 | 2024 | 3474 | 0.240 |
Why?
|
T-Lymphocytes | 8 | 2020 | 10266 | 0.240 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2021 | 846 | 0.230 |
Why?
|
Mice | 37 | 2024 | 82049 | 0.230 |
Why?
|
Receptor, Angiotensin, Type 1 | 3 | 2010 | 153 | 0.220 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2021 | 199 | 0.220 |
Why?
|
Complement Factor H | 1 | 2024 | 110 | 0.220 |
Why?
|
Neoplasm Metastasis | 6 | 2021 | 4913 | 0.220 |
Why?
|
Immunoconjugates | 5 | 2003 | 975 | 0.220 |
Why?
|
Immunoenzyme Techniques | 2 | 2017 | 1703 | 0.220 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2021 | 1124 | 0.210 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2830 | 0.210 |
Why?
|
Transplantation, Homologous | 9 | 2023 | 4834 | 0.200 |
Why?
|
Aldosterone | 3 | 2010 | 881 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 757 | 0.200 |
Why?
|
Interleukin-2 | 2 | 2024 | 1895 | 0.200 |
Why?
|
Male | 49 | 2024 | 364731 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2022 | 4648 | 0.200 |
Why?
|
Biopsy | 9 | 2021 | 6792 | 0.190 |
Why?
|
Angiotensin II | 3 | 2010 | 844 | 0.190 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11244 | 0.190 |
Why?
|
Retinal Degeneration | 2 | 2016 | 414 | 0.190 |
Why?
|
Myxoma | 1 | 2022 | 114 | 0.190 |
Why?
|
Skin Diseases | 2 | 2022 | 1085 | 0.190 |
Why?
|
Middle Aged | 31 | 2024 | 223487 | 0.190 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2433 | 0.180 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9262 | 0.180 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 344 | 0.180 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2019 | 183 | 0.180 |
Why?
|
Graft Survival | 8 | 2024 | 3887 | 0.180 |
Why?
|
Immunization, Passive | 1 | 2003 | 619 | 0.180 |
Why?
|
Limbus Corneae | 1 | 2022 | 144 | 0.180 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 50 | 0.180 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 68 | 0.180 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 62 | 0.170 |
Why?
|
Aged, 80 and over | 10 | 2021 | 59626 | 0.170 |
Why?
|
Penile Diseases | 1 | 2020 | 47 | 0.170 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2010 | 262 | 0.170 |
Why?
|
Angiomatosis | 1 | 2020 | 46 | 0.170 |
Why?
|
Scleroderma, Localized | 1 | 2020 | 85 | 0.170 |
Why?
|
Th1 Cells | 3 | 2016 | 1042 | 0.170 |
Why?
|
Pyoderma Gangrenosum | 1 | 2021 | 84 | 0.170 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2020 | 61 | 0.170 |
Why?
|
Fasciitis | 1 | 2020 | 66 | 0.170 |
Why?
|
Scrotum | 1 | 2020 | 117 | 0.170 |
Why?
|
Aged | 23 | 2024 | 171502 | 0.170 |
Why?
|
Epithelium, Corneal | 1 | 2022 | 247 | 0.170 |
Why?
|
Mutation | 5 | 2016 | 30237 | 0.170 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 41 | 0.160 |
Why?
|
Keratin-15 | 1 | 2019 | 22 | 0.160 |
Why?
|
Edema | 1 | 2023 | 765 | 0.160 |
Why?
|
Ice | 1 | 2020 | 102 | 0.160 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.160 |
Why?
|
Intestines | 4 | 2006 | 1909 | 0.160 |
Why?
|
Paraneoplastic Syndromes | 1 | 2020 | 154 | 0.160 |
Why?
|
Liver | 1 | 2014 | 7578 | 0.150 |
Why?
|
Female | 44 | 2024 | 397187 | 0.150 |
Why?
|
Neural Crest | 1 | 2021 | 278 | 0.150 |
Why?
|
Dermatitis, Exfoliative | 1 | 2018 | 27 | 0.150 |
Why?
|
Melanosis | 1 | 2019 | 93 | 0.150 |
Why?
|
Immunosuppressive Agents | 8 | 2022 | 4206 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2022 | 374 | 0.150 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2017 | 8 | 0.150 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2018 | 139 | 0.150 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 47 | 0.150 |
Why?
|
Adenylate Kinase | 1 | 2018 | 102 | 0.150 |
Why?
|
Mouth Mucosa | 1 | 2020 | 437 | 0.150 |
Why?
|
Models, Biological | 1 | 2014 | 9497 | 0.150 |
Why?
|
Mice, Inbred C3H | 7 | 2006 | 915 | 0.150 |
Why?
|
Up-Regulation | 3 | 2019 | 4149 | 0.150 |
Why?
|
Chemokines | 1 | 2022 | 963 | 0.140 |
Why?
|
Melanins | 1 | 2019 | 292 | 0.140 |
Why?
|
Signal Transduction | 11 | 2021 | 23648 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2020 | 416 | 0.140 |
Why?
|
Dermatomyositis | 1 | 2020 | 259 | 0.140 |
Why?
|
Mucous Membrane | 1 | 2020 | 659 | 0.140 |
Why?
|
Neoplasms | 8 | 2024 | 22371 | 0.140 |
Why?
|
Cells, Cultured | 5 | 2022 | 19025 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2015 | 148 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5704 | 0.140 |
Why?
|
Lichen Planus, Oral | 1 | 2017 | 57 | 0.140 |
Why?
|
Transplantation Tolerance | 2 | 2003 | 633 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2018 | 4415 | 0.140 |
Why?
|
Epidermis | 1 | 2019 | 539 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2020 | 404 | 0.130 |
Why?
|
Mycosis Fungoides | 1 | 2018 | 169 | 0.130 |
Why?
|
Adult | 23 | 2024 | 223646 | 0.130 |
Why?
|
Cicatrix | 2 | 2020 | 798 | 0.130 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2016 | 56 | 0.130 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 41 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13677 | 0.130 |
Why?
|
Talc | 1 | 2016 | 48 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2846 | 0.130 |
Why?
|
Eosinophilia | 1 | 2020 | 556 | 0.130 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 200 | 0.130 |
Why?
|
MutS Homolog 2 Protein | 1 | 2016 | 200 | 0.130 |
Why?
|
Exanthema | 1 | 2020 | 503 | 0.130 |
Why?
|
Estradiol | 2 | 2008 | 1951 | 0.130 |
Why?
|
Antigens, Differentiation | 4 | 2001 | 921 | 0.130 |
Why?
|
Protective Agents | 1 | 2017 | 151 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 197 | 0.130 |
Why?
|
Adenoma, Sweat Gland | 1 | 2015 | 16 | 0.130 |
Why?
|
Ceramides | 1 | 2017 | 203 | 0.120 |
Why?
|
Tissue Donors | 2 | 2014 | 2381 | 0.120 |
Why?
|
Neisseriaceae Infections | 1 | 2014 | 5 | 0.120 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.120 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 822 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 627 | 0.120 |
Why?
|
Methyltransferases | 1 | 2018 | 373 | 0.120 |
Why?
|
Cryosurgery | 1 | 2020 | 479 | 0.120 |
Why?
|
Leukemia, Myeloid | 1 | 2018 | 693 | 0.120 |
Why?
|
Purpura Fulminans | 1 | 2014 | 21 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1146 | 0.120 |
Why?
|
Rats, Transgenic | 1 | 2014 | 70 | 0.120 |
Why?
|
Naphthalenes | 1 | 2015 | 198 | 0.120 |
Why?
|
Face | 1 | 2020 | 1031 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1966 | 0.120 |
Why?
|
Histocompatibility Testing | 1 | 2016 | 716 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.110 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2540 | 0.110 |
Why?
|
Facial Neoplasms | 1 | 2015 | 126 | 0.110 |
Why?
|
Mice, Nude | 5 | 2020 | 3623 | 0.110 |
Why?
|
Paracrine Communication | 1 | 2016 | 279 | 0.110 |
Why?
|
Bone Marrow Cells | 2 | 2016 | 2414 | 0.110 |
Why?
|
Facial Injuries | 1 | 2015 | 191 | 0.110 |
Why?
|
Intestine, Small | 3 | 2001 | 1217 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 183 | 0.110 |
Why?
|
Immunoblotting | 1 | 2017 | 1648 | 0.110 |
Why?
|
Interleukin-17 | 2 | 2020 | 924 | 0.110 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3604 | 0.110 |
Why?
|
Zebrafish | 2 | 2022 | 3035 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 905 | 0.110 |
Why?
|
Immunoprecipitation | 1 | 2016 | 874 | 0.110 |
Why?
|
Cell Movement | 3 | 2019 | 5213 | 0.110 |
Why?
|
Interleukin-6 | 2 | 2022 | 3229 | 0.110 |
Why?
|
Rats | 8 | 2024 | 23782 | 0.110 |
Why?
|
Lymphedema | 1 | 2020 | 527 | 0.110 |
Why?
|
Consanguinity | 1 | 2015 | 460 | 0.110 |
Why?
|
Trans-Activators | 3 | 2016 | 2857 | 0.110 |
Why?
|
Axilla | 1 | 2016 | 623 | 0.110 |
Why?
|
Proteinuria | 1 | 2006 | 611 | 0.110 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 826 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2017 | 480 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2732 | 0.110 |
Why?
|
Liver Diseases | 1 | 2022 | 1305 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1220 | 0.110 |
Why?
|
Prognosis | 7 | 2018 | 30009 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2024 | 2100 | 0.100 |
Why?
|
Melanocytes | 2 | 2015 | 509 | 0.100 |
Why?
|
Soft Tissue Infections | 1 | 2014 | 168 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2885 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3447 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2023 | 1837 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1061 | 0.100 |
Why?
|
Erythropoietin | 1 | 2017 | 718 | 0.100 |
Why?
|
Myocardium | 4 | 2010 | 4790 | 0.100 |
Why?
|
Interferon-gamma | 3 | 2016 | 3161 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2017 | 1194 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 393 | 0.100 |
Why?
|
Mice, Inbred C57BL | 15 | 2022 | 22380 | 0.100 |
Why?
|
Histones | 2 | 2014 | 2601 | 0.100 |
Why?
|
Immunotherapy | 5 | 2021 | 4754 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2013 | 291 | 0.100 |
Why?
|
Lymphotoxin-alpha | 1 | 2001 | 94 | 0.100 |
Why?
|
Psoriasis | 1 | 2019 | 926 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 749 | 0.090 |
Why?
|
Retina | 3 | 2017 | 2662 | 0.090 |
Why?
|
Heart | 3 | 2013 | 4446 | 0.090 |
Why?
|
Pedigree | 2 | 2016 | 4539 | 0.090 |
Why?
|
Mice, Inbred BALB C | 7 | 2017 | 6231 | 0.090 |
Why?
|
Needles | 1 | 2024 | 461 | 0.090 |
Why?
|
Dermatology | 1 | 2021 | 905 | 0.090 |
Why?
|
RNA, Untranslated | 1 | 2014 | 455 | 0.090 |
Why?
|
Models, Animal | 4 | 2021 | 2122 | 0.090 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2006 | 58 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1105 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2017 | 710 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 507 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4120 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2024 | 81760 | 0.090 |
Why?
|
Sodium, Dietary | 1 | 2013 | 426 | 0.080 |
Why?
|
Adiponectin | 2 | 2013 | 1117 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2059 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 737 | 0.080 |
Why?
|
Software | 1 | 2024 | 4480 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2010 | 706 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 707 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1885 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18349 | 0.080 |
Why?
|
DNA Helicases | 1 | 2014 | 854 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2018 | 3612 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 870 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2014 | 778 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1744 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3517 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1642 | 0.080 |
Why?
|
Cell Line, Tumor | 7 | 2019 | 17142 | 0.080 |
Why?
|
Hydrogels | 1 | 2024 | 744 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1907 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3573 | 0.080 |
Why?
|
Th2 Cells | 2 | 2001 | 1078 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4413 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1767 | 0.080 |
Why?
|
Lymphocyte Activation | 4 | 2016 | 5505 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2010 | 255 | 0.080 |
Why?
|
Young Adult | 6 | 2019 | 60066 | 0.070 |
Why?
|
Gene Expression | 2 | 2019 | 7601 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5891 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 18065 | 0.070 |
Why?
|
Histone Demethylases | 1 | 2010 | 328 | 0.070 |
Why?
|
Collagen | 1 | 2016 | 2645 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1599 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1628 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 591 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3049 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1524 | 0.070 |
Why?
|
Glucose | 1 | 2018 | 4352 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3670 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 951 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11930 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2003 | 588 | 0.060 |
Why?
|
Surgical Flaps | 1 | 2015 | 1682 | 0.060 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.060 |
Why?
|
Antibodies | 2 | 2024 | 2421 | 0.060 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2709 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3445 | 0.060 |
Why?
|
Apoptosis | 5 | 2020 | 9527 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1673 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2024 | 1596 | 0.060 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2017 | 257 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39354 | 0.060 |
Why?
|
Complement C3d | 1 | 2024 | 21 | 0.060 |
Why?
|
NF-kappa B | 1 | 2003 | 2494 | 0.060 |
Why?
|
Heart Transplantation | 3 | 2003 | 3301 | 0.060 |
Why?
|
Stromal Cells | 2 | 2022 | 1337 | 0.050 |
Why?
|
Mice, Knockout | 6 | 2018 | 14488 | 0.050 |
Why?
|
RNA, Messenger | 7 | 2008 | 12801 | 0.050 |
Why?
|
CD40 Ligand | 2 | 2003 | 528 | 0.050 |
Why?
|
Rats, Wistar | 3 | 2008 | 1890 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 3 | 2010 | 167 | 0.050 |
Why?
|
Kidney | 2 | 2006 | 7064 | 0.050 |
Why?
|
Spironolactone | 1 | 2006 | 415 | 0.050 |
Why?
|
Busulfan | 1 | 2003 | 259 | 0.050 |
Why?
|
Laminin | 1 | 2024 | 405 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5804 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 24 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4064 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5789 | 0.050 |
Why?
|
Phenotype | 2 | 2022 | 16726 | 0.050 |
Why?
|
Antigens, CD | 5 | 2003 | 4035 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1209 | 0.050 |
Why?
|
Complement Activation | 1 | 2024 | 447 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2003 | 564 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1606 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2021 | 107 | 0.050 |
Why?
|
STAT4 Transcription Factor | 2 | 2001 | 94 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 286 | 0.050 |
Why?
|
Sunlight | 1 | 2022 | 337 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 2939 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2020 | 130 | 0.040 |
Why?
|
Ovariectomy | 2 | 2008 | 613 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4916 | 0.040 |
Why?
|
Collagen Type I | 1 | 2024 | 620 | 0.040 |
Why?
|
STAT6 Transcription Factor | 2 | 2001 | 196 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 22290 | 0.040 |
Why?
|
Keratosis | 1 | 2020 | 81 | 0.040 |
Why?
|
Current Procedural Terminology | 1 | 2021 | 101 | 0.040 |
Why?
|
Histamine Antagonists | 1 | 2020 | 94 | 0.040 |
Why?
|
Aminopyridines | 1 | 2024 | 580 | 0.040 |
Why?
|
Acute Disease | 3 | 2018 | 7243 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 701 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4355 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8741 | 0.040 |
Why?
|
Pigmentation Disorders | 1 | 2020 | 105 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Ear, External | 1 | 2020 | 165 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 481 | 0.040 |
Why?
|
Injections, Intraperitoneal | 2 | 2000 | 411 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4423 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1151 | 0.040 |
Why?
|
Parotid Neoplasms | 1 | 2021 | 158 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 855 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 973 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 570 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2227 | 0.040 |
Why?
|
RNA | 2 | 2022 | 2722 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 342 | 0.040 |
Why?
|
Adipokines | 2 | 2013 | 309 | 0.040 |
Why?
|
Erythema | 1 | 2020 | 261 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2003 | 510 | 0.040 |
Why?
|
Sus scrofa | 1 | 2020 | 430 | 0.040 |
Why?
|
Administration, Topical | 1 | 2020 | 704 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2019 | 265 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 687 | 0.040 |
Why?
|
Phosphorylation | 2 | 2020 | 8316 | 0.040 |
Why?
|
Cohort Studies | 2 | 2022 | 41753 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2018 | 73 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6975 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3620 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2014 | 16044 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3803 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 683 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 219 | 0.040 |
Why?
|
Phosphoserine | 1 | 2018 | 204 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 65379 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1124 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 494 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 1015 | 0.040 |
Why?
|
Embryo, Nonmammalian | 1 | 2021 | 910 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2020 | 559 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8542 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8743 | 0.030 |
Why?
|
Adipose Tissue | 3 | 2016 | 3334 | 0.030 |
Why?
|
Spleen | 3 | 2006 | 2296 | 0.030 |
Why?
|
Oligodendroglioma | 1 | 2018 | 274 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12795 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7609 | 0.030 |
Why?
|
Pancreas | 1 | 2023 | 1699 | 0.030 |
Why?
|
Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
Peyer's Patches | 1 | 2006 | 120 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2020 | 620 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1738 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2021 | 1563 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1625 | 0.030 |
Why?
|
Adolescent | 4 | 2019 | 89169 | 0.030 |
Why?
|
Microscopy, Polarization | 1 | 2016 | 88 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 71 | 0.030 |
Why?
|
Estrogen Receptor beta | 1 | 2006 | 171 | 0.030 |
Why?
|
Neck | 1 | 2020 | 736 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10099 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8142 | 0.030 |
Why?
|
Base Sequence | 2 | 2016 | 12422 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1646 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12171 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9118 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2017 | 401 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1316 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 1942 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 281 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2006 | 2747 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.030 |
Why?
|
Head | 1 | 2020 | 926 | 0.030 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 111 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1751 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2016 | 203 | 0.030 |
Why?
|
Osteocytes | 1 | 2016 | 193 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2016 | 412 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1243 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9419 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5997 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 684 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 909 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1495 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2016 | 594 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 699 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5341 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 730 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
Triglycerides | 2 | 2013 | 2464 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15833 | 0.030 |
Why?
|
Testosterone | 1 | 2024 | 2491 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1561 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 753 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 656 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2003 | 175 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 418 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1540 | 0.030 |
Why?
|
Judgment | 1 | 2014 | 273 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2006 | 581 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2605 | 0.020 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2001 | 9 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 465 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2001 | 14 | 0.020 |
Why?
|
Cytokines | 2 | 2022 | 7452 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2459 | 0.020 |
Why?
|
Computational Biology | 1 | 2024 | 3567 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1886 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1255 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1960 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 594 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 605 | 0.020 |
Why?
|
Child | 2 | 2019 | 80917 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4329 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13668 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3284 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2006 | 5902 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1334 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1623 | 0.020 |
Why?
|
Metformin | 1 | 2018 | 909 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6124 | 0.020 |
Why?
|
Endothelial Cells | 2 | 2016 | 3589 | 0.020 |
Why?
|
Body Weight | 2 | 2013 | 4627 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3703 | 0.020 |
Why?
|
Obesity | 2 | 2013 | 13091 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1996 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1351 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2057 | 0.020 |
Why?
|
Vascular Malformations | 1 | 2015 | 469 | 0.020 |
Why?
|
Lymphocyte Transfusion | 1 | 2000 | 232 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 3610 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1388 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 909 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1406 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1854 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2010 | 479 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1660 | 0.020 |
Why?
|
Adipocytes | 1 | 2016 | 1199 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4786 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2050 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4939 | 0.020 |
Why?
|
Time Factors | 4 | 2018 | 40220 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4280 | 0.020 |
Why?
|
Protein Kinase C-delta | 1 | 2008 | 115 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10873 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2000 | 825 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2040 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2001 | 651 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2152 | 0.020 |
Why?
|
Microcirculation | 1 | 2003 | 1281 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2006 | 2359 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2934 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 208 | 0.020 |
Why?
|
Methylation | 1 | 2010 | 1078 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2006 | 2149 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 279 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2334 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 664 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5802 | 0.020 |
Why?
|
Abdomen | 1 | 2003 | 1136 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 2004 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2575 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3428 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2430 | 0.020 |
Why?
|
Streptozocin | 1 | 2006 | 190 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3728 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9561 | 0.020 |
Why?
|
Mice, SCID | 1 | 2000 | 2627 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2810 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8509 | 0.020 |
Why?
|
PPAR gamma | 1 | 2008 | 487 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1754 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 54924 | 0.010 |
Why?
|
Osteopontin | 1 | 2006 | 311 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7213 | 0.010 |
Why?
|
Hypertrophy | 1 | 2006 | 562 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8052 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3074 | 0.010 |
Why?
|
Systole | 1 | 2006 | 937 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4363 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10632 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9384 | 0.010 |
Why?
|
Isoantigens | 1 | 2006 | 562 | 0.010 |
Why?
|
Albuminuria | 1 | 2006 | 658 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 12252 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8747 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 13045 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6019 | 0.010 |
Why?
|
Transplantation | 1 | 2003 | 221 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18415 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2003 | 594 | 0.010 |
Why?
|
Decision Making | 1 | 2014 | 3953 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20225 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2253 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5926 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1599 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13013 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3986 | 0.010 |
Why?
|
Jejunum | 1 | 2001 | 475 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6610 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6431 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13422 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74944 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17623 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3348 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4585 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 4477 | 0.010 |
Why?
|
Diet | 1 | 2013 | 8089 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7876 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3740 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24318 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8543 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20762 | 0.010 |
Why?
|